Baxter (NYSE:BAX) today announced the global launch of its PrisMax 2, meant to simplify the delivery of continuous renal replacement therapy (CRRT) and other organ support therapies. The next-gen PrisMax 2 system includes new features from the company’s TrueVue digital health portfolio. There’s also the PrismaLung+ blood-gas exchanger that delivers extracorporeal carbon dioxide removal therapy […]
Avalyn Pharma announced today that it observed statistically significant success in a study of its aerosolized pulmonary fibrosis treatment. Seattle-based Avalyn presented data from a 24-week Phase 1/2 clinical study at the ISAM conference in Boise, Idaho. The data covered two dose regimens of AP01, a formulation of pirfenidone optimized for delivery through inhalation in patients […]
CorVent Medical announced that it received CE mark approval for its Respond-19 ventilator and is preparing to launch it in Europe. Santa Clara, Calif.-based CorVent’s Respond-19 ventilator allows hospitals to treat more patients suffering from acute respiratory distress syndrome (ARDS). The system received FDA emergency use authorization (EUA) for primary critical care use in December […]
Teleflex (NYSE:TFX) announced today that it agreed to sell a significant portion of its respiratory business to Medline Industries for $286 million. Total consideration for the sale amounts to $286 million, reduced by $12 million of working capital to be retained by Teleflex, according to a news release. Assets set to be divested generated revenues […]
Lyra Therapeutics (NSDQ:LYRA) shares finished up on the day despite first-quarter results that missed the consensus earnings forecast. The Watertown, Mass.-based chronic rhinosinusitis (CRS) treatment developer posted losses of -$7.8 million, or -60¢ per share for the three months ended March 31, 2021, for a -84.4% bottom-line slide. Lyra’s EPS of -60¢ came in 48¢ behind […]
Electromed (NSDQ:ELMD) shares dipped slightly after hours today despite third-quarter results that topped the consensus forecast. The New Prague, Minn.-based company posted profits of $223,771, or 3¢ per share, on sales of $8.8 million for the three months ended March 31, 2021, for a -65.7% bottom-line slide on sales growth of 0.5%. Electromed’s EPS of […]
Teva Pharmaceuticals (NYSE:TEVA) shares stood firm before hours today on first-quarter earnings that topped the consensus forecast. The Tel Aviv, Israel-based company posted profits of $84 million, or 7¢ per share, on sales of $4 billion for the three months ended March 31, 2021, for a more-than tripled bottom-line despite a sales decline of -8.6%. Get […]
Valeo Pharma announced today that it closed an upsized private placement worth more than $6.6 million. Montreal, Canada-based Valeo issued 6,645 unsecured, non-convertible debenture units at a purchase price of $1,000 per unit, totaling gross proceeds of $6.645 million, according to a news release. Get the full story at our sister site, Drug Delivery Business News.
The FDA recently told healthcare facilities they can start to limit the decontamination and reuse of disposable masks. An increase in the domestic supply of new masks approved by NIOSH has made the practice less necessary, the agency said. Get the full story on our sister site, Medical Design & Outsourcing.
Getinge announced today that it received FDA 510(k) clearance for three products to expand its Servo platform of ventilators. Gothenburg, Sweden-based Getinge’s latest clearances are for new software options for the Servo-u and Servo-n ventilators, as well as clearance for use of the new Servo-u MR ventilator in the MRI room, according to a news release. […]
LivaNova (NSDQ:LIVN) announced today that it received FDA 510(k) clearance for its B-Capta system integrated into the S5 heart-lung machine. London-based LivaNova’s B-Capta, a new, in-line, blood-gas monitoring system is to be integrated into the S5 HLM to easily and accurately monitor arterial and venous blood gas parameters even during long and complex pediatric and […]